RxDoctor Payments Data

Kevin Herman, MD

Vascular & Interventional Radiology · Teaneck, NJNPI 1619107703

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (48.8%), education and consulting fees — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 77.4% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2022 at $37,519 and has fallen 50.6% since, to $18,534 in 2025. Among vascular & interventional radiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$153,940in general payments, 2019–2025

Across 300 payments — averaging $513.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$119K
  • Cordis US CORP.$10K
  • Cardinal Health 200 LLC$5K
  • Cardiovascular Systems Inc.$4K
  • Reflow Medical Inc$3K
  • Endologix LLC$2K
  • plus $10K from 30 others
$94,576in research payments, 2019–2025

Across 25 payments — averaging $3783.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$32K
  • Inari Medical, Inc.$25K
  • Medalliance LLC$24K
  • M.a. Med Alliance S.A.$14K
$30,000in ownership & investment interests, 2019–2025

Across 3 payments — averaging $10,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Vasorum USA Inc.$30K

What the payments were for

  • Consulting fees$18,82512%
  • Speaking & faculty fees$2,1001%
  • Travel & lodging$2,7572%
  • Food & beverage$11,7058%
  • Education$43,38128%
  • Other$75,17249%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$153,940 in reported general payments places this provider in the 95th percentile of 111 vascular & interventional radiology providers in New Jersey.

See all vascular & interventional radiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$546,208
Medicare patients
342
Services billed
3,887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate96$1,014
Prasugrel Hcl12$785
Cilostazol15$217

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Teaneck

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →